Inactive Provider
This provider's NPI has been deactivated on 04/20/2026. The information on this page is historical and may no longer be current.
Total Payments
$469,826
2024 Payments
$4,586
Companies
47
Transactions
1,215
Medicare Patients
2,792
Medicare Billing
$254,802
Payment Breakdown by Category
Other$255,055 (54.3%)
Research$147,128 (31.3%)
Consulting$33,026 (7.0%)
Food & Beverage$20,705 (4.4%)
Travel$13,735 (2.9%)
Education$177.34 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $252,205 | 144 | 53.7% |
| Unspecified | $147,128 | 22 | 31.3% |
| Consulting Fee | $33,026 | 15 | 7.0% |
| Food and Beverage | $20,705 | 972 | 4.4% |
| Travel and Lodging | $13,735 | 48 | 2.9% |
| Honoraria | $2,850 | 2 | 0.6% |
| Education | $177.34 | 12 | 0.0% |
Payments by Type
General
$322,698
1,193 transactions
Research
$147,128
22 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $241,815 | 224 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $77,714 | 110 | $0 (2024) |
| Celgene Corporation | $57,358 | 88 | $0 (2019) |
| Amgen Inc. | $35,429 | 71 | $0 (2024) |
| LEO Pharma Inc. | $18,183 | 48 | $0 (2023) |
| PFIZER INC. | $16,612 | 49 | $0 (2024) |
| Incyte Corporation | $4,573 | 31 | $0 (2024) |
| Janssen Biotech, Inc. | $4,130 | 86 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $2,586 | 58 | $0 (2024) |
| GENZYME CORPORATION | $2,053 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,586 | 93 | ABBVIE INC. ($2,349) |
| 2023 | $17,120 | 183 | Amgen Inc. ($7,955) |
| 2022 | $21,012 | 130 | ABBVIE INC. ($16,120) |
| 2021 | $32,278 | 115 | AbbVie Inc. ($17,114) |
| 2020 | $49,107 | 126 | AbbVie Inc. ($28,555) |
| 2019 | $104,870 | 164 | AbbVie, Inc. ($56,445) |
| 2018 | $95,240 | 157 | AbbVie, Inc. ($40,842) |
| 2017 | $145,612 | 247 | AbbVie, Inc. ($73,047) |
All Payment Transactions
1,215 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.84 | General |
| 12/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Inflammation & Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: Immunology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.16 | General |
| Category: Immunology | ||||||
| 12/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.09 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.70 | General |
| Category: Immunology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.67 | General |
| Category: Immunology | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.52 | General |
| Category: Immunology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.57 | General |
| Category: Immunology | ||||||
| 11/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: Immunology | ||||||
| 11/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: DERMATOLOGY | ||||||
| 10/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Dermatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| P10-023 | AbbVie, Inc. | $75,232 | 8 |
| P10-023 | AbbVie Inc. | $22,704 | 4 |
| A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA (Adalimumab) in Adult Patients with Chronic Plaque Psoriasis (PS) | ABBVIE INC. | $9,288 | 3 |
| Chronic Plaque Psoriasis (Ps) Registry | ABBVIE INC. | $7,224 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 701 | 1,605 | $166,869 | $59,319 |
| 2022 | 12 | 676 | 1,686 | $172,935 | $59,548 |
| 2021 | 10 | 697 | 1,611 | $122,042 | $78,148 |
| 2020 | 13 | 718 | 1,442 | $89,643 | $57,787 |
Total Patients
2,792
Total Services
6,344
Medicare Billing
$254,802
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 167 | 294 | $58,041 | $20,777 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 74 | $20,427 | $7,691 | 37.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 59 | 81 | $21,102 | $7,672 | 36.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 74 | 74 | $18,140 | $6,627 | 36.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 54 | 100 | $15,162 | $5,135 | 33.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 41 | 72 | $9,274 | $3,234 | 34.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 46 | $5,749 | $2,129 | 37.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 38 | 251 | $3,850 | $1,528 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,984 | $1,455 | 36.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 65 | 127 | $3,980 | $1,443 | 36.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 18 | 19 | $4,420 | $1,277 | 28.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 90 | 456 | $2,740 | $350.53 | 12.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 195 | 367 | $59,674 | $25,598 | 42.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 64 | 95 | $23,839 | $8,526 | 35.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 54 | 118 | $20,209 | $6,012 | 29.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 60 | 60 | $14,440 | $4,822 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 46 | $11,005 | $4,819 | 43.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 27 | 57 | $7,111 | $2,493 | 35.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 45 | 368 | $8,560 | $2,163 | 25.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 22 | 22 | $8,800 | $1,671 | 19.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 26 | 30 | $2,948 | $1,367 | 46.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 60 | 110 | $6,332 | $1,178 | 18.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 12 | 12 | $1,997 | $594.55 | 29.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 78 | 401 | $8,020 | $304.70 | 3.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 250 | 608 | $64,957 | $43,629 | 67.2% |
About Dr. Joseph Eastern, M.D
Dr. Joseph Eastern, M.D is a Specialist healthcare provider based in Belleville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1447395991.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Eastern, M.D has received a total of $469,826 in payments from pharmaceutical and medical device companies, with $4,586 received in 2024. These payments were reported across 1,215 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($252,205).
As a Medicare-enrolled provider, Eastern has provided services to 2,792 Medicare beneficiaries, totaling 6,344 services with total Medicare billing of $254,802. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Belleville, NJ
- Active Since 02/21/2007
- Last Updated 01/18/2026
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447395991
Products in Payments
- Humira (Biological) $150,423
- Otezla (Drug) $90,146
- COSENTYX (Biological) $75,091
- HUMIRA (Biological) $39,324
- SKYRIZI (Biological) $30,023
- ENSTILAR (Drug) $18,111
- EUCRISA (Drug) $16,547
- Skyrizi (Biological) $13,491
- OPZELURA (Drug) $4,573
- XOLAIR (Biological) $2,418
- Otezla (Biological) $2,255
- RINVOQ (Biological) $2,133
- DUPIXENT (Biological) $2,114
- ILUMYA (Biological) $2,035
- Sitavig (Drug) $1,503
- TargaDox (Drug) $1,162
- TALTZ (Drug) $647.00
- Sotyktu (Drug) $587.18
- TREMFYA (Drug) $458.53
- Tremfya (Drug) $445.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Belleville
Dr. Robert Spira, M.d, M.D
Specialist — Payments: $33,856
Specialist $33,856
Dr. Rama Reddy, Md, MD
Specialist — Payments: $14,687
Specialist $14,687
Dr. Gary Vicik, M.d, M.D
Specialist — Payments: $13,448
Specialist $13,448
Dr. Syed Abdul-Aziz, Md, MD
Specialist — Payments: $10,667
Specialist $10,667
Dr. Mark Feldman, M.d, M.D
Specialist — Payments: $3,822
Specialist $3,822
Dr. Rita Komboz, M.d, M.D
Specialist — Payments: $3,349
Specialist $3,349